Free Trial
OTCMKTS:AUGX

Augmedix (AUGX) Stock Price, News & Analysis

Augmedix logo
$2.35 0.00 (0.00%)
As of 10/2/2024

About Augmedix Stock (OTCMKTS:AUGX)

Key Stats

Today's Range
$2.35
$2.35
50-Day Range
$2.35
$2.35
52-Week Range
$0.73
$6.25
Volume
N/A
Average Volume
635,746 shs
Market Capitalization
$115.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

Remove Ads
Receive AUGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Augmedix and its competitors with MarketBeat's FREE daily newsletter.

AUGX Stock News Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

AUGX Stock Analysis - Frequently Asked Questions

Augmedix's stock was trading at $2.35 at the beginning of the year. Since then, AUGX stock has increased by 0.0% and is now trading at $2.35.
View the best growth stocks for 2025 here
.

Augmedix, Inc. (OTCMKTS:AUGX) announced its quarterly earnings data on Monday, March, 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.16) by $0.01. The company had revenue of $8.75 million for the quarter, compared to analyst estimates of $8.52 million. Augmedix had a negative trailing twelve-month return on equity of 980.09% and a negative net margin of 57.70%.

Shares of AUGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Augmedix investors own include Meta Platforms (META), Urban Outfitters (URBN), Arista Networks (ANET), Capital Southwest (CSWC), NVIDIA (NVDA), PACCAR (PCAR) and Turkcell Iletisim Hizmetleri A.S. (TKC).

Company Calendar

Last Earnings
3/27/2023
Today
4/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Health Information Services
Sub-Industry
Business Services
Current Symbol
OTCMKTS:AUGX
Fax
N/A
Employees
710
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-24,450,000.00
Pretax Margin
-57.23%

Debt

Sales & Book Value

Annual Sales
$51.58 million
Price / Cash Flow
N/A
Book Value
$0.10 per share
Price / Book
23.50

Miscellaneous

Free Float
36,316,000
Market Cap
$115.07 million
Optionable
Not Optionable
Beta
-0.22
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (OTCMKTS:AUGX) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners